it is quite alot to look back over that has been underway over the first quarter of 2011 - certainly it appears alot has been happening & incoming revenue has come very close to expenditre over the period, it is encouraging to see the company is certainly not sitting still...
so for $178k cash burn look at what has been achieved -
** Mediimune / AstraZeneca - screening ongoing
** Pfizer - screening ongoing
** PYC / XL-Protein - pilot study
** PYC / Isogenica - Proof of concept completed on tech. compatability
** Proof of concept completed on TBI candidate
** Succesfull completion of objectives in intial Roche stage
** Phenomica spin-off put in motion
** US intracellular screening patent granted
** Share Placement negotiated
** ongoing negotiations with major pharmaceutical companies
** presentations ongoing - JP Morgan (NY) - BioTrinity (UK) etc.
So hows the next 9 months going to play out ? :-) :-)
PYC Price at posting:
6.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)